title: Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies.
abstract: OBJECTIVE
  Autoimmune thyroid disease frequently aggravates or develops after delivery through the immune rebound mechanism. However, little is known about the post-partum development of autoimmune hepatitis (AIH).
  
  
  METHODS
  We examined 18 patients who developed liver dysfunction after delivery or abortion. Serial examinations were performed in 10 of these cases. Anti-cytochrome 2D6(CYP2D6) antibodies, which are liver-specific autoantibodies, were measured using a sensitive radioligand assay.
  
  
  RESULTS
  Liver dysfunction developed between 1 and 5 months after delivery and was mild and transient except in one case. One patient developed liver dysfunction after abortion. Eight of 10 patients who underwent serial serologic examinations were positive for anti-nuclear antibodies, but anti-smooth muscle antibodies were positive in only three patients, and were present only at low titer. None of the patients had anti-mitochondrial antibodies. Nine of these 10 cases were diagnosed as definite or probable AIH according to the international scoring system of AIH. Nine of these 10 patients were positive for anti-CYP2D6 antibodies. The increase of anti-CYP2D6 antibodies was slightly delayed compared to increase of aminotransferase. Of the 18 patients who developed liver dysfunction, 15 cases (83.3%) were positive for anti-CYP2D6 antibodies. Of the 77 post-partum control subjects only three (3.9%) had positive antibodies.
  
  
  CONCLUSIONS
  Autoimmune hepatitis developed after delivery, similarly to the development of post-partum autoimmune thyroid disease. Measurement of anti-CYP2D6 antibodies by a sensitive radioligand assay could provide information important for the detection of post-partum AIH.
authors.affiliation: Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. yizumi@labo.med.osaka-u.ac.jp
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Izumi
authors.forename: Susumu
authors.initials: S
authors.lastname: Tanaka
authors.forename: Yoh
authors.initials: Y
authors.lastname: Hidaka
authors.forename: Yuki
authors.initials: Y
authors.lastname: Shimaoka
authors.forename: Ke-ita
authors.initials: KI
authors.lastname: Tatsumi
authors.forename: Toru
authors.initials: T
authors.lastname: Takano
authors.forename: Akira
authors.initials: A
authors.lastname: Kaneko
authors.forename: Kazumi
authors.initials: K
authors.lastname: Oku
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Amino
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D016022:Case-Control Studies; D019389:Cytochrome P-450 CYP2D6 / Q000276:immunology*; D005260:Female; D019693:Hepatitis, Autoimmune / Q000201:enzymology / Q000209:etiology / Q000276:immunology*; D006801:Humans; D011247:Pregnancy; D011644:Puerperal Disorders / Q000201:enzymology / Q000209:etiology / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D019389:Cytochrome P-450 CYP2D6